In March 2025, the company introduced new programs for just a direct-to-consumer presenting of its Wegovy weight loss drug. The company recognized a fresh pharmacy, named NovoCare, which might charge customers $499 each month for entry to the drug, fewer than fifty percent the expense of the drug by means of other pharmaceutical distribution networ